WALTHAM, Mass., Sept. 29, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR) announced today that Abbott's acquisition of Alere is intended to close on October 3, 2017. The announcement follows receipt of all regulatory clearances necessary for closing.
Alere intends to request that the New York Stock Exchange cease trading of Alere's common stock before market open on October 3, 2017.
About Alere

Ad Statistics
Times Displayed: 26624
Times Visited: 594 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Alere believes that when diagnosing and monitoring health conditions, Knowing now matters™. Alere delivers reliable and actionable information by providing rapid diagnostic tests, enhancing clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for cardiometabolic disease, infectious disease and toxicology.
SOURCE Alere Inc.